Correlation Between Emergent Biosolutions and Allakos

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Emergent Biosolutions and Allakos at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Emergent Biosolutions and Allakos into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Emergent Biosolutions and Allakos, you can compare the effects of market volatilities on Emergent Biosolutions and Allakos and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Emergent Biosolutions with a short position of Allakos. Check out your portfolio center. Please also check ongoing floating volatility patterns of Emergent Biosolutions and Allakos.

Diversification Opportunities for Emergent Biosolutions and Allakos

-0.03
  Correlation Coefficient

Good diversification

The 3 months correlation between Emergent and Allakos is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Emergent Biosolutions and Allakos in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allakos and Emergent Biosolutions is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Emergent Biosolutions are associated (or correlated) with Allakos. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allakos has no effect on the direction of Emergent Biosolutions i.e., Emergent Biosolutions and Allakos go up and down completely randomly.

Pair Corralation between Emergent Biosolutions and Allakos

Considering the 90-day investment horizon Emergent Biosolutions is expected to under-perform the Allakos. But the stock apears to be less risky and, when comparing its historical volatility, Emergent Biosolutions is 1.04 times less risky than Allakos. The stock trades about -0.41 of its potential returns per unit of risk. The Allakos is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest  24.00  in Allakos on December 1, 2024 and sell it today you would earn a total of  4.00  from holding Allakos or generate 16.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Emergent Biosolutions  vs.  Allakos

 Performance 
       Timeline  
Emergent Biosolutions 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Emergent Biosolutions has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's fundamental drivers remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Allakos 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Allakos has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's essential indicators remain quite persistent which may send shares a bit higher in April 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Emergent Biosolutions and Allakos Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Emergent Biosolutions and Allakos

The main advantage of trading using opposite Emergent Biosolutions and Allakos positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Emergent Biosolutions position performs unexpectedly, Allakos can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allakos will offset losses from the drop in Allakos' long position.
The idea behind Emergent Biosolutions and Allakos pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Complementary Tools

Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format